세계의 IV 플러쉬 시린지 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for IV Flush Syringe was estimated to be worth US$ 579 million in 2024 and is forecast to a readjusted size of US$ 929 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on IV Flush Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An IV Flush Syringe is a sterile, single-use medical consumable designed to maintain the patency of venous access devices and reduce catheter-related complications. Whether provided as prefilled syringes or prepared at point-of-care per protocol, these syringes deliver standardized flush solutions to clear indwelling catheters, help prevent thrombosis, and lower infection risk. Key product attributes include sterile packaging, dose standardization, and ease of use-features that minimize contamination opportunities during preparation and administration while improving clinical workflow. As infection prevention and infusion safety have become central quality metrics, IV flush syringes are evolving from routine consumables into strategic clinical-safety tools integrated into standardized care pathways and hospital procurement priorities.In 2024, global IV Flush Syringe production reached approximately 1053 m units, with an average global market price of around US$ 0.55 perunit

Heightened regulatory emphasis on infection prevention and infusion safety is prompting healthcare providers to adopt single-use, prefilled, or standardized flush solutions within clinical protocols and procurement frameworks. These policy drivers create institutional demand for IV flush syringes. At the same time, hospitals' need to improve nursing efficiency, reduce preparation time, and minimize human error is accelerating the shift from manual preparation to commercially supplied, standardized products. Leading medtech and consumables companies have signalled in investor communications and annual reports that capacity expansion and product innovation in prefilled flush solutions are priority strategic initiatives-fostering rapid advances in manufacturing, supply chain, and commercialization capabilities. Integration of standardized packaging and traceability with electronic inventory systems further enables buyers to balance compliance and cost, enlarging sustainable demand.

High-quality sterile manufacturing and reliable supply are core challenges: prefilled solutions demand GMP-level filling capacity and resilient supply chains, requiring substantial capital and operational commitment and exposing suppliers to risk during supply shocks. Regulatory heterogeneity across jurisdictions complicates cross-border launches and adds to certification burdens. Clinical expectations around material compatibility, solution stability, and user-friendly packaging necessitate continuous R&D and rigorous quality control. Finally, failure to seamlessly integrate products with hospital information systems and inventory workflows can slow clinical adoption and reduce customer retention.

Downstream procurement is moving from ad-hoc consumable purchases toward integrated, process-oriented solutions: hospitals increasingly evaluate products based on regulatory credentials, ease of use, and system interoperability, while training, monitoring, and quality assurance services are becoming part of purchasing decisions. Scenario-specific formats-such as small-volume pediatric syringes, chemo-optimized variants, and syringes with closed-system caps-are gaining preference. Manufacturers are enhancing customer value by extending product portfolios (e.g., color-coded caps, traceable barcodes) and offering enablement services, which elevates downstream demand toward higher quality and higher-margin offerings.

This report aims to provide a comprehensive presentation of the global market for IV Flush Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IV Flush Syringe by region & country, by Type, and by Application.

The IV Flush Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IV Flush Syringe.

Market Segmentation

By Company

• BD
• Medline
• Medefil
• B. Braun
• Cardinal Health
• Weigao Group
• Jiangsu Impex Technology
• Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
• Shandong Zhongbaokang
• Nam Kwang Chemical Pharmaceuticals
• Guangdong Aixide Pharmaceutical Co., Ltd.
• Guerbet
• Sterisets
• Aquabiliti

Segment by Type

• Saline IV Flush Syringe
• Heparin IV Flush Syringe

Segment by Application

• Hospital
• Clinic
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of IV Flush Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of IV Flush Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of IV Flush Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 IV Flush Syringe Product Introduction
• 1.2 Global IV Flush Syringe Market Size Forecast
  • 1.2.1 Global IV Flush Syringe Sales Value (2020-2031)
  • 1.2.2 Global IV Flush Syringe Sales Volume (2020-2031)
  • 1.2.3 Global IV Flush Syringe Sales Price (2020-2031)
• 1.3 IV Flush Syringe Market Trends & Drivers
  • 1.3.1 IV Flush Syringe Industry Trends
  • 1.3.2 IV Flush Syringe Market Drivers & Opportunity
  • 1.3.3 IV Flush Syringe Market Challenges
  • 1.3.4 IV Flush Syringe Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global IV Flush Syringe Players Revenue Ranking (2024)
• 2.2 Global IV Flush Syringe Revenue by Company (2020-2025)
• 2.3 Global IV Flush Syringe Players Sales Volume Ranking (2024)
• 2.4 Global IV Flush Syringe Sales Volume by Company Players (2020-2025)
• 2.5 Global IV Flush Syringe Average Price by Company (2020-2025)
• 2.6 Key Manufacturers IV Flush Syringe Manufacturing Base and Headquarters
• 2.7 Key Manufacturers IV Flush Syringe Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of IV Flush Syringe
• 2.9 IV Flush Syringe Market Competitive Analysis
  • 2.9.1 IV Flush Syringe Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by IV Flush Syringe Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Flush Syringe as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Saline IV Flush Syringe
  • 3.1.2 Heparin IV Flush Syringe
• 3.2 Global IV Flush Syringe Sales Value by Type
  • 3.2.1 Global IV Flush Syringe Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global IV Flush Syringe Sales Value, by Type (2020-2031)
  • 3.2.3 Global IV Flush Syringe Sales Value, by Type (%) (2020-2031)
• 3.3 Global IV Flush Syringe Sales Volume by Type
  • 3.3.1 Global IV Flush Syringe Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global IV Flush Syringe Sales Volume, by Type (2020-2031)
  • 3.3.3 Global IV Flush Syringe Sales Volume, by Type (%) (2020-2031)
• 3.4 Global IV Flush Syringe Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Others
• 4.2 Global IV Flush Syringe Sales Value by Application
  • 4.2.1 Global IV Flush Syringe Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global IV Flush Syringe Sales Value, by Application (2020-2031)
  • 4.2.3 Global IV Flush Syringe Sales Value, by Application (%) (2020-2031)
• 4.3 Global IV Flush Syringe Sales Volume by Application
  • 4.3.1 Global IV Flush Syringe Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global IV Flush Syringe Sales Volume, by Application (2020-2031)
  • 4.3.3 Global IV Flush Syringe Sales Volume, by Application (%) (2020-2031)
• 4.4 Global IV Flush Syringe Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global IV Flush Syringe Sales Value by Region
  • 5.1.1 Global IV Flush Syringe Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global IV Flush Syringe Sales Value by Region (2020-2025)
  • 5.1.3 Global IV Flush Syringe Sales Value by Region (2026-2031)
  • 5.1.4 Global IV Flush Syringe Sales Value by Region (%), (2020-2031)
• 5.2 Global IV Flush Syringe Sales Volume by Region
  • 5.2.1 Global IV Flush Syringe Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global IV Flush Syringe Sales Volume by Region (2020-2025)
  • 5.2.3 Global IV Flush Syringe Sales Volume by Region (2026-2031)
  • 5.2.4 Global IV Flush Syringe Sales Volume by Region (%), (2020-2031)
• 5.3 Global IV Flush Syringe Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America IV Flush Syringe Sales Value, 2020-2031
  • 5.4.2 North America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe IV Flush Syringe Sales Value, 2020-2031
  • 5.5.2 Europe IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific IV Flush Syringe Sales Value, 2020-2031
  • 5.6.2 Asia Pacific IV Flush Syringe Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America IV Flush Syringe Sales Value, 2020-2031
  • 5.7.2 South America IV Flush Syringe Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa IV Flush Syringe Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa IV Flush Syringe Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions IV Flush Syringe Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions IV Flush Syringe Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions IV Flush Syringe Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions IV Flush Syringe Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States IV Flush Syringe Sales Value, 2020-2031
  • 6.3.2 United States IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe IV Flush Syringe Sales Value, 2020-2031
  • 6.4.2 Europe IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China IV Flush Syringe Sales Value, 2020-2031
  • 6.5.2 China IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan IV Flush Syringe Sales Value, 2020-2031
  • 6.6.2 Japan IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea IV Flush Syringe Sales Value, 2020-2031
  • 6.7.2 South Korea IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia IV Flush Syringe Sales Value, 2020-2031
  • 6.8.2 Southeast Asia IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia IV Flush Syringe Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India IV Flush Syringe Sales Value, 2020-2031
  • 6.9.2 India IV Flush Syringe Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India IV Flush Syringe Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 BD
  • 7.1.1 BD Company Information
  • 7.1.2 BD Introduction and Business Overview
  • 7.1.3 BD IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 BD IV Flush Syringe Product Offerings
  • 7.1.5 BD Recent Development
• 7.2 Medline
  • 7.2.1 Medline Company Information
  • 7.2.2 Medline Introduction and Business Overview
  • 7.2.3 Medline IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Medline IV Flush Syringe Product Offerings
  • 7.2.5 Medline Recent Development
• 7.3 Medefil
  • 7.3.1 Medefil Company Information
  • 7.3.2 Medefil Introduction and Business Overview
  • 7.3.3 Medefil IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Medefil IV Flush Syringe Product Offerings
  • 7.3.5 Medefil Recent Development
• 7.4 B. Braun
  • 7.4.1 B. Braun Company Information
  • 7.4.2 B. Braun Introduction and Business Overview
  • 7.4.3 B. Braun IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 B. Braun IV Flush Syringe Product Offerings
  • 7.4.5 B. Braun Recent Development
• 7.5 Cardinal Health
  • 7.5.1 Cardinal Health Company Information
  • 7.5.2 Cardinal Health Introduction and Business Overview
  • 7.5.3 Cardinal Health IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cardinal Health IV Flush Syringe Product Offerings
  • 7.5.5 Cardinal Health Recent Development
• 7.6 Weigao Group
  • 7.6.1 Weigao Group Company Information
  • 7.6.2 Weigao Group Introduction and Business Overview
  • 7.6.3 Weigao Group IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Weigao Group IV Flush Syringe Product Offerings
  • 7.6.5 Weigao Group Recent Development
• 7.7 Jiangsu Impex Technology
  • 7.7.1 Jiangsu Impex Technology Company Information
  • 7.7.2 Jiangsu Impex Technology Introduction and Business Overview
  • 7.7.3 Jiangsu Impex Technology IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Jiangsu Impex Technology IV Flush Syringe Product Offerings
  • 7.7.5 Jiangsu Impex Technology Recent Development
• 7.8 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd.
  • 7.8.1 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Company Information
  • 7.8.2 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Introduction and Business Overview
  • 7.8.3 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • 7.8.5 Fuzhou Haiwang Fuyao Pharmaceutical Co., Ltd. Recent Development
• 7.9 Shandong Zhongbaokang
  • 7.9.1 Shandong Zhongbaokang Company Information
  • 7.9.2 Shandong Zhongbaokang Introduction and Business Overview
  • 7.9.3 Shandong Zhongbaokang IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Shandong Zhongbaokang IV Flush Syringe Product Offerings
  • 7.9.5 Shandong Zhongbaokang Recent Development
• 7.10 Nam Kwang Chemical Pharmaceuticals
  • 7.10.1 Nam Kwang Chemical Pharmaceuticals Company Information
  • 7.10.2 Nam Kwang Chemical Pharmaceuticals Introduction and Business Overview
  • 7.10.3 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Nam Kwang Chemical Pharmaceuticals IV Flush Syringe Product Offerings
  • 7.10.5 Nam Kwang Chemical Pharmaceuticals Recent Development
• 7.11 Guangdong Aixide Pharmaceutical Co., Ltd.
  • 7.11.1 Guangdong Aixide Pharmaceutical Co., Ltd. Company Information
  • 7.11.2 Guangdong Aixide Pharmaceutical Co., Ltd. Introduction and Business Overview
  • 7.11.3 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Guangdong Aixide Pharmaceutical Co., Ltd. IV Flush Syringe Product Offerings
  • 7.11.5 Guangdong Aixide Pharmaceutical Co., Ltd. Recent Development
• 7.12 Guerbet
  • 7.12.1 Guerbet Company Information
  • 7.12.2 Guerbet Introduction and Business Overview
  • 7.12.3 Guerbet IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Guerbet IV Flush Syringe Product Offerings
  • 7.12.5 Guerbet Recent Development
• 7.13 Sterisets
  • 7.13.1 Sterisets Company Information
  • 7.13.2 Sterisets Introduction and Business Overview
  • 7.13.3 Sterisets IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Sterisets IV Flush Syringe Product Offerings
  • 7.13.5 Sterisets Recent Development
• 7.14 Aquabiliti
  • 7.14.1 Aquabiliti Company Information
  • 7.14.2 Aquabiliti Introduction and Business Overview
  • 7.14.3 Aquabiliti IV Flush Syringe Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Aquabiliti IV Flush Syringe Product Offerings
  • 7.14.5 Aquabiliti Recent Development

8 Industry Chain Analysis

• 8.1 IV Flush Syringe Industrial Chain
• 8.2 IV Flush Syringe Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 IV Flush Syringe Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 IV Flush Syringe Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer